Continuing Professional Development for Providers: Buprenorphine
8:00 AM - 12:00 PM
Sherwood Arts Center
22689 SW Pine St., Sherwood, OR 97140
This training held in partnership with Washington County.
Who Should Attend: This event is intended for prescribers in primary care or specialty practice settings.
CMEs: Participants may earn up to 3 AMA PRA Category 1 Credits™.
Cost: $30 per person, includes continuing medical education credits and breakfast.
Join us for a 4-hour breakfast presentation on Buprenorphine, a medication used for detoxification, opioid replacement therapy, and pain management. This event is intended for prescribers in primary care or specialty practice settings.
Lead speaker Andrea Rubenstein, MD, chief of the department of pain medicine at Kaiser Permanente Santa Rosa, California, will review taper planning of opioids and how and when to integrate buprenorphine products into a pain management strategy.
Speaker Amanda Risser, MD, who focuses on addiction medicine at Oregon Health & Science University, will give recommendations on buprenorphine/naloxone (Suboxone) prescribing for addiction within the primary care setting.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of OHSU School of Medicine and FamilyCare Health. The OHSU School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
OHSU School of Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.